Featured Posts from Our CEO

Featured Posts from Our CEO2017-03-24T12:47:26+00:00

Indivior’s Experimental Drug to Fight Opioid Addiction is Approved by the US FDA

Laurel Habel, Ph.D, from TPMG's Division of Research, describes Indivior as a promising alternative to the current addiction medication and believes it will be helpful to patients.

World’s Most Impactful Researchers List Includes Kaiser Permanente Northern California Scientist and Oncologist

TPMG’s Alan Go, MD, from the Division of Research, and oncologist Louis Fehrenbacher, MD, were named as Highly Cited Researchers in clinical medicine for 2017, indicating exceptional scientific impact.

Drivers for Survivors Free Ride Service for Cancer Patients Also Provides Companionship

Sundeep Nayak, MD, a radiologist at KP San Leandro, is quoted in an article about our partnership with Drivers for Survivors that provides free transportation and companionship for cancer patients.